Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2

Molecular Cell

Volumn 6, Issue 3, 2000, Pages 693-704

  Schwaller, Juerg ^a   Parganas, Evan ^b   Wang, Demin ^b   Cain, Danielle ^a   Aster, Jon C ^a   Williams, Ifor R ^c   Lee, Chien Kuo ^d   Gerthner, Rachel ^d   Kitamura, Toshio ^e   Frantsve, Julie ^a   Anastasiadou, Ema ^a   Loh, Mignon L ^a   Levy, David E ^d   Ihle, James N ^b,f   Gilliland, D Gary ^a,f  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TOKYO   (Japan)

^f HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

JANUS KINASE; ONCOSTATIN M; STAT1 PROTEIN; STAT5 PROTEIN; STAT5B PROTEIN; VIRUS FUSION PROTEIN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; COMPARATIVE ANATOMY; CONTROLLED STUDY; GENETIC TRANSDUCTION; HEMATOPOIETIC CELL; LYMPHOPROLIFERATIVE DISEASE; MOUSE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PATHOGENESIS; VIRUS CELL TRANSFORMATION; VIRUS EXPRESSION;

ANIMALIA; JANUS; MURINAE; UNIDENTIFIED RETROVIRUS;

EID: 0033639119     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(00)00067-8     Document Type: Article

References (57)

1. Bcl-2-independent Bcr-Abl-mediated resistance to apoptosis: Protection is correlated with up regulation of Bcl-xL
2. Stat3 as an oncogene
3. Regulation of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor expression by oncostatin M
4. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl
5. Constitutive activation of JAKs and STATs in BCR/ABL-expressing cell lines and peripheral blood cells derived from leukemic patients
6. JAK-STAT signalling induced by the v-abl oncogene
7. STATs and gene regulation
8. IL-3 dependent regulation of Bcl-XL gene expression by STAT5 in a bone marrow derived cell line
9. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease
10. BCR/ABL, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice
11. Hematologic disease induced in BALB/C mice by a BCR/ABL retrovirus is influenced by the infection conditions
12. Kat: A high-efficiency retroviral transduction system for primary human T lymphocytes
13. B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT)1 and STAT3 constitutively phosphorylated on serine residues
14. Efficient transplantation of BCR/ABL-induced chronic myelogenous leukemia-like syndrome in mice
15. Activated Stat related transcription factors in acute leukemia
16. Oncostatin M production and regulation by human polymorphonuclear neutrophils
17. Most primitive hematopoietic stem cells are stimulated to cycle rapidly after treatment with 5-fluorouracil
18. Versatile retroviral vectors for potential use in gene therapy
19. Signaling through the hematopoietic cytokine receptors
20. STATs: Signal transducers and activators of transcription
21. Signaling by the cytokine receptor superfamily
22. p210 and p190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members
23. Dominant negative mutants implicate STAT5 in myeloid cell proliferation and neutrophil differentiation
24. Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer
25. Retrovirus-mediated gene transfer of NPM/ALK causes lymphoid malignancy in mice
26. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia
27. Promoter-dependent synergy between glucocorticoid receptor and Stat5 in the activation of beta-casein gene transcription
28. Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue
29. Developmental abnormalities in mice transgenic for bovine oncostatin M
30. SOCS3 is essential in the regulation of fetal liver erythropoiesis
31. CIS, a cytokine inducible inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation
32. Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21(WAF1/Cip1) by STAT5
33. Transcriptional regulation of the cyclin D1 promoter by STAT5: Its involvement in cytokine-dependent growth of hematopoietic cells
34. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway
35. Inhibition of acute lymphoblastic leukaemia by a JAK2 inhibitor
36. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells
37. In vitro expansion of murine multipotential hematopoietic progenitors from the embryonic aorta-gonad-mesonephros region
38. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells
39. Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation
40. Selective regulation of Bcl-XI by a JAK kinase-dependent pathway is bypassed in murine hematopoietic malignancies
41. Jak2 is essential for signaling through a variety of cytokine receptors
42. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow
43. Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia
44. Cytokine rescue of p53-dependent apoptosis and cell cycle arrest is mediated by distinct Jak kinase signaling pathways
45. Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes
46. Stat5a/b contribute to IL-7 induced B cell precursor expansion but Abl and BCR/ABL induced transformation are independent of Stat5
47. Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia
48. Erythropoietin can induce the expression of Bcl-x(L) through Stat5 in erythopoietin-dependent progenitor cell lines
49. Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/-mice: A direct role for Stat5 in Bcl-XL induction
50. Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins
51. Pathogenetic mechanisms in chronic myeloproliferative disorders: Polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia
52. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses
53. Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response
54. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines
55. Expression of signal transducers and activators of transcription proteins in acute myeloid leukemia blasts
56. Mouse oncostatin M: An immediate early gene induced by multiple cytokines through the JAK-STAT5 pathway
57. BCR/ABL efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: A novel model for chronic myelogenous leukemia